The goal of this study was to assess the use of a phosphodiesterase type 5 (PDE5) inhibitor for relief of symptoms from chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Daily use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback